Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are ...

An international research group led by The University of Osaka has developed scODIN, a novel computational tool to classify cell types from ...

MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC-seq ...

In June, Google DeepMind took the wraps off AlphaGenome, its latest machine learning model for biological discovery. While ...

The hippocampus is an important brain region known to support various cognitive (i.e., mental) processes, including the ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...

The last time I wrote an article on Sana Biotechnology (NASDAQ:SANA) it was with respect to an article entitled "Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus". It is still set to ...